SOD1 and uveitis: Therefore a noninvasive topical SOD1 nanoformat that can be conveniently applied as eye drops by a patient if shown successful as a therapeutic modality could be a major breakthrough in treatment of uveitis and possibly other inflammatory conditions of the eye.